COMPARISON OF FREQUENCY OF ACHIEVING TARGET HEMOGLOBIN LEVELS WITH INTRAMUSCULAR AND INTRAVENOUS IRON THERAPY IN IRONDEFICIENCY ANEMIA OF PREGNANCY

Objectives: The objective of this study is to compare the frequency of achieving the target hemoglobin levels with
intramuscular and intravenous therapy in iron deficiency anemia of pregnancy.
Material and Methods: A total number of 60 patients with iron deficiency anemia of pregnancy were included after
history, examination and laboratory workup. Patients were divided into two groups. Group 1 and 2 each had 30 women.
The SPSS version 12 was applied to the data.
Results: Group 1, mean age was 23 ± 4.6 years with the gestational age of 27 ± 5.3 weeks. Group 2, mean age was
25 ± 5.1 years and mean gestational age was 25 ± 4.9 weeks. Mean number of doses of inj. iron sucrose given intravenously
to group 1 were 6 ± 1. Mean number of doses of inj. iron sorbitol given intramuscularly to group 2 were 12 ± 0.
Intravenous iron sucrose therapy (group 1) acquired better results than the intramuscular iron sorbitol therapy (group 2).
Conclusion:Intravenous iron therapy is more effective than Intramuscular iron therapy in treatment of iron deficiency
anemia during pregnancy.
Key Words: Iron deficiency anemia, pregnancy, intravenous iron sucrose, intramuscular iron sor